2003
DOI: 10.1046/j.1537-2995.2003.00319.x
|View full text |Cite
|
Sign up to set email alerts
|

GUTI: a new antigen in the Cromer blood group system

Abstract: This study describes a novel high- incidence antigen (GUTI) in the Cromer blood group system characterized by the amino acid arginine at position 206 in SCR4 of DAF. The GUTI-negative proband has a substitution mutation that predicts for histidine at this position.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
21
0

Year Published

2003
2003
2013
2013

Publication Types

Select...
4
3
2

Relationship

1
8

Authors

Journals

citations
Cited by 25 publications
(21 citation statements)
references
References 20 publications
0
21
0
Order By: Relevance
“…Three new antigens of high incidence have been added: CROM11 (GUTI) [58], CROM12 (SERF) [59], and CROM13 (ZENA) [60] are associated with Arg206His, Pro182Leu and His208Gln in CD55, respectively.…”
Section: Blood Group Systemsmentioning
confidence: 99%
“…Three new antigens of high incidence have been added: CROM11 (GUTI) [58], CROM12 (SERF) [59], and CROM13 (ZENA) [60] are associated with Arg206His, Pro182Leu and His208Gln in CD55, respectively.…”
Section: Blood Group Systemsmentioning
confidence: 99%
“…An antigen of very high incidence, named GUTI, has been given the number CROM11. The CROM:−11 phenotype is associated with a mutation encoding Arg206His in the CD55 glycoprotein [12].…”
Section: Cromer Systemmentioning
confidence: 99%
“…No GUTI+ samples were found in our 122 samples comparedto 6 of 114 (5.3%) of the Mapuche Indians 3 . Althoughboth the Choctaw and the Mapuche are part of the Amerindian migrationfrom Asia, the Mapuche are considered to be an isolate especiallyfrom a linguistic point (M. Foster, personal communication).…”
mentioning
confidence: 81%
“…By use of procedures similar to those reported by Storry andcolleagues, 3 we employed DAFSCR4Fand DAFSCR4R primers to amplify genomic DNA by PCR. The RFLP analysiswas performed on the amplified samples using the Tai I enzymefor digestion and a 2 percent agarose gel containing ethidium bromide.A known GUTI+ heterozygous DNA sample, provided by M. Reidat the New York Blood Center, was used as a positive control.…”
mentioning
confidence: 99%